| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-03 |
| filingDate |
1993-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58dd9be600e85a2c39a3e94fd5bb6947
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1a9c0bd2c7111f4d787187b52e45c28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9655c70d03b99f64525ab2e899086b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96ba27129d14ce7e62bc1896bd2f8e68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec6303e0118505f84d624c88011b429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a68604522e58687740d198fe1339a30 |
| publicationDate |
1994-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0630385-A1 |
| titleOfInvention |
Potent peptide for stimulation of cytotoxic t lymphocytes specific for the hiv-1 envelope |
| abstract |
The invention relates to peptides having high activity in triggering a cytotoxic T lymphocyte response to the HIV-1 envelope glycoprotein gp160. The invention also relates to the activation of the peptides of residues 12 to 15 by proteolytic degradation into shorter peptides, as well as to general techniques intended to characterize these activation methods. |
| priorityDate |
1992-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |